CAS 932749-62-7

Histone Acetyltransferase Inhibitor II

CAS: 932749-62-7

Histone Acetyltransferase Inhibitor II is a selective and cell permeable inhibitor of p300 histone acetyltransferase(IC50 : 5 μM).with anti-acetylase activity

Formel: C₂₀H₁₆Br₂O₃

Reinheit: 97.13%

Farbe und Form: Solid

Molekulargewicht: 464.15

Ref: TM-T11563

trans-2,6-Bis(3-bromo-4-hydroxybenzylidene)cyclohexanone

CAS: 932749-62-7

Formel: C₂₀H₁₆Br₂O₃

Reinheit: 99%

Farbe und Form: Solid

Molekulargewicht: 464.1472

Ref: IN-DA003QXS

Histone Acetyltransferase Inhibitor II

CAS: 932749-62-7

Histone Acetyltransferase Inhibitor II

Reinheit: ≥95%

Molekulargewicht: 464.15g/mol

Ref: 54-BUP04981

Histone Acetyltransferase Inhibitor II

Kontrolliertes Produkt

CAS: 932749-62-7

Formel: C₂₀H₁₆Br₂O₃

Farbe und Form: Neat

Molekulargewicht: 464.147

Ref: TR-H456345

Histone Acetyltransferase Inhibitor II

CAS: 932749-62-7

Histone acetyltransferase inhibitor II is a histone acetyltransferase (HAT) inhibitor that is used in the treatment of cancer. It inhibits cellular transformation and tumor growth by binding to the polymerase chain, which prevents DNA synthesis and transcription. Histone Acetyltransferase Inhibitor II has been shown to have anti-cancer activity in a number of animal models of cancer, including gliomas and breast cancers. The drug also has an anti-inflammatory effect on the body, which may be due to its ability to inhibit prostaglandin synthesis. This drug is not potent enough to be used as a chemotherapeutic agent alone but can be added to other treatments for more effectiveness.

Formel: C₂₀H₁₆Br₂O₃

Reinheit: Min. 95%

Molekulargewicht: 464.15 g/mol

Ref: 3D-HMB74962